St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute — Kansas City, Missouri

St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

• Children's Mercy Hospital & Clinics
• Children's Mercy Hospital
• Children's Mercy Hospital - Department of Nephrology
• University of Kansas Medical Center
• University Of Kansas Cancer Center
• University of Missouri - Kansas City / The Children's Mercy Hospital
• University Health Truman Medical Center
• Children's Mercy Hospital/ID# 200221
• Saint Luke's Hospital/Marion Bloch Neuroscience Institute Dept of Regulatory
• VA Medical Center
• Saint Luke's Hospital of Kansas City Mid America
• Section of Pediatric Nephrology, Children's Mercy Hospitals and Clinics

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute?

St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute conducted?

St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute has 1 clinical trials on record. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Is St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute accredited by Crixeo Clinical Trials?

St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Hospital of Kansas City/St. Luke's Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.